Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$17,500.00

Development of Artificial Virus-like Particles for creating induced pluripotent stem cells for use in osteoporosis therapy.

EF 2009-10

Résumé
The ability to make embryonic-like stem cells from a patient's own cells will revolutionize medicine creating a multitude of regenerative cell-based therapies. Contrary to ES cells isolated from developing embryos, these cells carry the advantage of having the same genetic makeup as the patient they are derived from thus minimizing the chance of tissue rejection. To create these cells, however, reprogramming genes must be introduced into cells with high efficiency gene delivery systems. Typically viruses are used due to their high efficiency but they can be potentially dangerous causing cancer and immunological responses in some cases. The project I am proposing is to develop virus-like particles made up of combinational formulations of DNA-binding polymers encapsulated in lipids. These particles have been shown to have efficiencies comparable to some viruses and may be a viable alternative to making embryonic-like stem cells. These particles will be optimized for use on stem cells isolated from fat tissue which can be obtained from patients with low-risk liposuction. After being reprogrammed and their embryonic-like status confirmed through a number of molecular biological techniques they will be used to develop a regenerative therapy for bone diseases such as osteoporosis. The reprogrammed cells will be introduced to growth factors that stimulate differentiation into bone forming osteoblast cells. These cells will then be tested for their bone-forming ability with a number of in vitro assays and will eventually be tested in a mouse model for osteoporosis. The success of this study will result in a method to create embryonic-like stem cells for individual patients without using potentially dangerous viruses and to demonstrate their use in a bone regenerative therapy.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
200360
Name
Fitzsimmons Ross E
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Development of Artificial Virus-like Particles for creating induced pluripotent stem cells for use in osteoporosis therapy.
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adipose Derived Stromal Cells; Cationic Lipids; Cationic Polymers; Induced Pluripotent Stem Cells; Osteoporosis; Reprogramming; Transfection
Abstract
The ability to make embryonic-like stem cells from a patient's own cells will revolutionize medicine creating a multitude of regenerative cell-based therapies. Contrary to ES cells isolated from developing embryos, these cells carry the advantage of having the same genetic makeup as the patient they are derived from thus minimizing the chance of tissue rejection. To create these cells, however, reprogramming genes must be introduced into cells with high efficiency gene delivery systems. Typically viruses are used due to their high efficiency but they can be potentially dangerous causing cancer and immunological responses in some cases. The project I am proposing is to develop virus-like particles made up of combinational formulations of DNA-binding polymers encapsulated in lipids. These particles have been shown to have efficiencies comparable to some viruses and may be a viable alternative to making embryonic-like stem cells. These particles will be optimized for use on stem cells isolated from fat tissue which can be obtained from patients with low-risk liposuction. After being reprogrammed and their embryonic-like status confirmed through a number of molecular biological techniques they will be used to develop a regenerative therapy for bone diseases such as osteoporosis. The reprogrammed cells will be introduced to growth factors that stimulate differentiation into bone forming osteoblast cells. These cells will then be tested for their bone-forming ability with a number of in vitro assays and will eventually be tested in a mouse model for osteoporosis. The success of this study will result in a method to create embryonic-like stem cells for individual patients without using potentially dangerous viruses and to demonstrate their use in a bone regenerative therapy.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fitzsimmons, Ross E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~